Inactive Instrument

News Big Rock Partners Acquisition Corp. Nasdaq

Equities

BRPAU

US0894822024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : NRx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024	15/05
NRx Pharmaceuticals, Inc. to Participate in the EF Hutton Annual Global Conference on May 15, 2024	09/05	AQ
NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data	06/05	DJ
NRx Pharmaceuticals, Inc. Announces Final Clinical Trial Results	06/05	CI
NRx Pharmaceuticals : Notice of Acceleration - Form 8-K	02/05	PU
NRx Pharmaceuticals Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression	01/05	AQ
NRx Pharmaceuticals, Inc. Announces Promising Findings in Phase 2B/3 Clinical Trial of Nrx-101 Vs. Lurasidone for Treatment of Suicidal Bipolar Depression	30/04	CI
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock	19/04	AQ
NRx Pharmaceuticals Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement	19/04	AQ
NRx Pharmaceuticals Receives Notice of Listing Compliance From Nasdaq	18/04	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Fed Policymakers Speeches	18/04	MT
Top Premarket Decliners	18/04	MT
NRx Pharmaceuticals Looking to Sell Shares to Fund General Corporate Activities; Shares Slump Premarket	18/04	MT
NRx Pharmaceuticals Looking to Sell Shares to Fund General Corporate Activities, Working Capital	18/04	MT
NRx Pharmaceuticals, Inc. Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics	17/04	CI
NRx Pharmaceuticals Announces Development of New, Proprietary Formulation of HTX-100	16/04	AQ
NRx Pharmaceuticals, Inc. Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)	15/04	CI
NRx Pharmaceuticals Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression	09/04	AQ
NRx Pharmaceuticals, Inc. Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression	08/04	CI
NRx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	02/04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Big Rock Partners Acquisition Corp. Nasdaq

Equities

BRPAU

US0894822024

Summary

Filters